METHOD OF T1-WEIGHTED MAGNETIC RESONANCE IMAGING OF RES ORGANS
    23.
    发明公开
    METHOD OF T1-WEIGHTED MAGNETIC RESONANCE IMAGING OF RES ORGANS 失效
    RES器官的T1加权磁共振成像方法

    公开(公告)号:EP0896546A2

    公开(公告)日:1999-02-17

    申请号:EP97914482.0

    申请日:1997-03-27

    IPC分类号: A61K49

    CPC分类号: A61K49/186 A61K49/1863

    摘要: The invention provides a method of contrast enhanced MR angiography of the human or non-human animal body, said method comprising administering into the vasculature thereof a contrast effective amount of a contrast agent composition comprising magnetic particles having an r2/r1 ratio of no more than 5, and, at a time when sufficient of said magnetic particles remain in the vasculature to provide positive contrast enhancement thereof in a T1-weighted image while sufficient magnetic particles have been taken up into an organ of the reticuloendothelial system to provide negative contrast enhancement thereof in said T1-weighted image, generating a T1-weighted image magnetic resonance image of at least said organ.

    摘要翻译: 本发明提供了一种人或非人动物体的造影增强MR血管造影的方法,所述方法包括向其血管中施用造影剂有效量的造影剂组合物,所述造影剂组合物包含r2 / r1比率不超过 如图5所示,并且在足够的所述磁性颗粒保留在脉管系统中以在T1加权图像中提供其正增强的对比度的同时,足够的磁性颗粒已被摄取到网状内皮系统的器官中以提供其负对比度增强 在所述T1加权图像中,生成至少所述器官的T1加权图像磁共振图像。

    IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS
    28.
    发明授权
    IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS 失效
    改进造影剂

    公开(公告)号:EP0660724B1

    公开(公告)日:1998-07-01

    申请号:EP93919497.3

    申请日:1993-09-03

    IPC分类号: A61K49/00

    摘要: Proteinaceous gas- or gas precursor-containing microbubble contrast agents, e.g. for use in ultrasound and/or MR imaging, in which the protein matrix is crosslinked by reaction with a bifunctional aldehyde (e.g. a dialdehyde such as glutaraldehyde or an α,β-unsaturated aldehyde such as acrolein) in an aqueous medium at substantially neutral pH exhibit improved in vivo and storage stabilities, particularly if the matrix is also reacted with a Schiff's base reducing agent such as a borohydride. Modification of the size distribution of such crosslinked proteinaceous gas-containing contrast agents, e.g. to reduce the mean size of the microbubbles, further enhances their stability and permits preparation of novel contrast agents having a particularly narrow microbubble size distribution.

    A DEVICE AND A METHOD FOR MEASURING THROMBUS FORMATION TENDENCY
    30.
    发明授权
    A DEVICE AND A METHOD FOR MEASURING THROMBUS FORMATION TENDENCY 失效
    装置和方法用于测量血栓的倾向

    公开(公告)号:EP0677169B1

    公开(公告)日:1997-08-13

    申请号:EP94904350.9

    申请日:1993-12-29

    IPC分类号: G01N33/49

    CPC分类号: G01N11/08 G01N33/4905

    摘要: In a device for in vitro measurement of the tendency to form thrombi in people and animals under simulated in vivo conditions, the blood is pumped at a constant flow through flow channels (7) made of/coated with a thrombogenesis-promoting material, and the pressure difference between the pressures upstream and downstream of the thrombogenesis unit (6), due to a thrombus formed in the flow channel (7), is measured. A method for measuring the tendency to thrombogenesis is also described.